Foundation Urges European Parliament Intervention in CERN Funding Allocation for Advanced Cancer Detection Technology

The Crosetto Foundation for the Reduction of Cancer Deaths has issued an urgent call to Members of the European Parliament to intervene in what it describes as the misallocation of public funding at CERN. The foundation advocates for the adoption of Dario Crosetto's 3D-Flow technology, which it claims represents a breakthrough invention with the potential to revolutionize both particle physics and cancer detection while saving billions in taxpayer funds. This technology, recognized in 1993 by a scientific panel at FERMILAB, offers unparalleled flexibility, performance, and cost-effectiveness in processing ultra-high-data streams according to foundation statements.

Despite what the foundation calls proven superiority and successful demonstration of feasibility through a $1 million grant, CERN has continued investing in Field Programmable Gate Array-based architectures. These FPGA-based systems have repeatedly failed to meet performance requirements according to the foundation, resulting in significant financial waste. The 3D-Flow technology not only promises to enhance the efficiency of CERN's experiments but also underpins the 3D-Complete Body Screening, an advanced PET/CT technology for early disease detection. Crosetto's inventions have the potential to save lives by enabling early detection of cancer and other diseases while reducing healthcare costs and improving societal well-being.

The foundation has requested a public scientific meeting to compare CERN's current FPGA-based Level-1 Trigger system with Crosetto's 3D-Flow system. Technical specifications show the former consumes 650 kW for only 66 operations, while the latter requires just 6 kW for over 8,000 operations, offering what the foundation describes as clear advantages in both performance and cost-effectiveness. This efficiency differential represents a critical factor in the foundation's argument for technology adoption and funding reallocation.

The Crosetto Foundation's call to action emphasizes the need for transparency, accountability, and responsible use of taxpayer money. It highlights the importance of accelerating adoption of life-saving technologies and ensuring fair and open scientific evaluations. The foundation urges MEPs to submit a Parliamentary Question to address these issues and redirect funding toward what it characterizes as genuinely advanced science. This intervention at the European Parliament level represents a strategic move to leverage political oversight of scientific funding allocations at major research institutions like CERN.

The implications extend beyond particle physics research to public health outcomes, as the same underlying technology could transform medical imaging capabilities. Early disease detection through advanced screening technologies represents a crucial frontier in reducing cancer mortality rates worldwide. The foundation's advocacy connects scientific research funding decisions with tangible societal benefits, creating a compelling case for parliamentary intervention in research and development priorities at European scientific institutions.